Back Pain Clinical Trials 2024

What are the top hospitals conducting back pain research?

When it comes to finding innovative solutions for back pain, several top hospitals across the United States are leading the way in clinical trials. In Rochester, Minnesota, Mayo Clinic stands at the forefront with four active back pain trials and a total of seven completed trials since their first recorded study in 2005. Meanwhile, Rush University Medical Center in Chicago has emerged as an important player with two ongoing back pain trials and a track record of six previous studies dating back to their initial trial in 2014.

Down south, Vanderbilt University Medical Center in Nashville is also making strides in this area. With two active back pain trials and six completed studies to date - starting from their first recorded trial in 2017 - they contribute significantly to advancing our understanding of effective treatment options for individuals suffering from this condition. The University of Colorado Anschutz Medical Campus joins them with two current clinical trials focused on addressing back pain issues. While they may have conducted only three overall studies so far since beginning their exploration into this field just four years ago, it is evident that they are committed to making meaningful contributions.

Further east, the University of Pittsburgh plays a pivotal role by actively engaging in two ongoing back pain trials and having five successfully concluded investigations under its belt since initiating research efforts pertaining to this matter ten years ago (in 2011). These institutions serve as beacons of hope for patients seeking relief from chronic or debilitating back pain.

Back pain affects millions worldwide and can have profound impacts on daily life. By conducting these clinical trials and pushing boundaries within medical science, these hospitals strive not only to alleviate immediate discomfort but also pave the path towards long-term solutions for managing or even preventing future episodes of such discomforting conditions ensuring better quality lives for countless individuals globally

Which are the best cities for back pain clinical trials?

When it comes to back pain clinical trials, several cities offer promising research opportunities. New york City leads the way with 8 active trials, focusing on treatments such as Low Dose Tranexamic acid and Topical diclofenac. Boston, Massachusetts closely follows with 7 ongoing studies investigating CBD and Oxycodone or morphine sulfate immediate release (MSIR). Rochester, Minnesota also boasts 7 active trials exploring innovative interventions like the Angel® Concentrated Platelet Rich Plasma System. Montréal, Quebec and Pittsburgh, Pennsylvania contribute to this field of research as well with their respective ongoing studies. These cities provide individuals suffering from back pain access to cutting-edge clinical trials that may lead to improved treatments and relief in the future.

Which are the top treatments for back pain being explored in clinical trials?

Back pain sufferers can find solace in the ongoing exploration of various treatments through clinical trials. Topping the list is physical therapy, with three active trials and a total of 13 all-time back pain trials since its first listing in 2011. Another promising option is spinal manipulation therapy (SMT), which has two active and three all-time back pain trials to its credit since being listed in 2018. Additionally, both T'ai Chi and Qigong rehabilitation, as well as ED physical therapy, show potential with two active trials each for back pain relief. These innovative approaches offer hope for individuals seeking effective solutions to alleviate their back discomfort.

What are the most recent clinical trials for back pain?

Recent clinical trials have shed light on potential breakthroughs in the treatment of back pain. One notable trial investigated the effectiveness of combining ibuprofen, dexamethasone, and educational intervention as a comprehensive approach to managing back pain. Another study focused on the Primary Spine Provider Model, which aims to improve outcomes by involving specialized healthcare professionals in the care process. Additionally, research explored the use of THC/CBD and CBD alone for alleviating back pain symptoms. These trials offer hope for individuals struggling with this common ailment and may provide innovative solutions to enhance their quality of life.

What back pain clinical trials were recently completed?

Recently completed clinical trials for back pain show promising developments in the field. In April 2022, Scilex Pharmaceuticals concluded a trial investigating SP-103 as a potential treatment option. Additionally, Eli Lilly and Company made significant strides with their studies on back pain treatments, completing trials for LY3526318 in October 2021 and LY3556050 in May 2021. Neurana Pharmaceuticals also reached an important milestone with their Tolperisone Hydrochloride trial finishing in December 2020. Lastly, Eli Lilly's research on LY3016859 yielded results when their trial was completed in August 2020. These advancements contribute to our understanding of effective interventions for individuals suffering from back pain and offer hope for improved management strategies going forward.